Novo Nordisk A/S ADR buy BiotechBee
Start price
07.09.22
/
70%
€104.00
Target price
31.12.25
€180.00
Performance (%)
41.35%
End price
05.05.23
€147.00
Summary
This prediction ended on 05.05.23 with a price of €147.00. The BUY prediction by BiotechBee for Novo Nordisk A/S ADR saw massive gains of 41.35%. A total of €1.10 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | -0.362% | -0.362% | -44.340% | -68.231% |
| iShares Core DAX® | -0,82 % | -2,03 % | 9,73 % | 57,41 % |
| iShares Nasdaq 100 | -1,74 % | -5,35 % | -0,86 % | 80,46 % |
| iShares Nikkei 225® | 1,21 % | 6,38 % | 27,79 % | 62,93 % |
| iShares S&P 500 | -1,17 % | -3,46 % | 0,10 % | 55,84 % |
According to BiotechBee what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy mit Kursziel 180,0